Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults

Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India—Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity

(2016) Mohit Singla et al.   PLoS Neglected Tropical Diseases

Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice

(2016) Jieqiong Li et al.   Scientific Reports

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

(2015) Guntur Fibriansah et al.   Nature Communications

Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults

(2014) Nozomi Takeshita et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection

(2014) M. L. Moi et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

(2014) Tomohiro Ishikawa et al.   VACCINE

Co-positivity of anti-dengue virus and anti-Japanese encephalitis virus IgM in endemic area: co-infection or cross reactivity?

(2014) Kaleshwar Prasad Singh et al.   Asian Pacific Journal of Tropical Medicine

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

Mechanistic Study of Broadly Neutralizing Human Monoclonal Antibodies against Dengue Virus That Target the Fusion Loop

(2012) J. M. Costin et al.   JOURNAL OF VIROLOGY

Flaviviruses and flavivirus vaccines

(2012) Franz X. Heinz et al.   VACCINE

Dengue Virus Infection-Enhancing Activity in Serum Samples with Neutralizing Activity as Determined by Using FcγR-Expressing Cells

(2012) Meng Ling Moi et al.   PLoS Neglected Tropical Diseases

Pathogenesis of Japanese Encephalitis Virus Infection in a Golden Hamster Model and Evaluation of Flavivirus Cross-Protective Immunity

(2011) Angela Bosco-Lauth et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Dengue vaccines: progress and challenges

(2011) Beth-Ann G Coller et al.   CURRENT OPINION IN IMMUNOLOGY

Flavivirus-induced antibody cross-reactivity

(2011) K. L. Mansfield et al.   JOURNAL OF GENERAL VIROLOGY

Detection of Higher Levels of Dengue Viremia Using FcγR-Expressing BHK-21 Cells Than FcγR-Negative Cells in Secondary Infection but Not in Primary Infection

(2011) Meng Ling Moi et al.   JOURNAL OF INFECTIOUS DISEASES

Preexisting Japanese Encephalitis Virus Neutralizing Antibodies and Increased Symptomatic Dengue Illness in a School-Based Cohort in Thailand

(2011) Kathryn B. Anderson et al.   PLoS Neglected Tropical Diseases

Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate

(2010) Guillermo Posadas-Herrera et al.   VACCINE

Involvement of the Fc  receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection

(2009) M. L. Moi et al.   JOURNAL OF GENERAL VIROLOGY

A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells

(2009) Eiji Konishi et al.   JOURNAL OF VIROLOGICAL METHODS

Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine

(2008) Chang-Kweng Lim et al.   VIROLOGY